Mohammed A. M. Alhoot | Molecular Microbiology | Outstanding Scientist Award

Published on by NESIN Awards

Assoc. Prof. Dr. Mohammed A. M. Alhoot | Molecular Microbiology | Outstanding Scientist Award

Associate Professor of Medical Microbiology & Immunology at Management and Science University, Malaysia

Assoc. Prof. Dr. Mohammed AbdelFatah Mosa Al-Hoot is an accomplished academic and researcher in Medical Microbiology and Immunology, specializing in Virology and Molecular Microbiology. With a career spanning over two decades, he has made significant contributions to molecular virology, antiviral therapeutics, antimicrobial resistance, nanoparticle-based treatments, and infectious diseases. His research on dengue virus inhibition through siRNA and antiviral peptides, as well as nanoparticle antibacterials and phytochemical antiviral screening, has been widely recognized. He has authored more than 40 peer-reviewed publications, contributed book chapters, and holds a patent, with his work attracting over 600 citations globally. A leader in postgraduate supervision, curriculum development, and research ethics, Dr. Al-Hoot also serves as an editor and reviewer for international journals. His collaborative projects across countries, commitment to capacity building, and contributions to scientific knowledge have positioned him as a respected figure in the global research community.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Al-Hoot’s academic journey reflects a strong foundation in medical sciences and research excellence. He earned his Bachelor’s degree with honors in Medical Laboratory Sciences, followed by a Master’s in Microbiology, both of which equipped him with essential skills in laboratory diagnostics and infectious disease analysis. Building on this expertise, he pursued and completed a Ph.D. in Medical Microbiology, specializing in Medical Virology, at a leading university. His doctoral research focused on innovative antiviral strategies, laying the groundwork for his subsequent contributions to molecular virology and translational therapeutics. Throughout his education, Dr. Al-Hoot consistently demonstrated academic distinction, earning scholarships and recognition for his scholarly performance. His academic qualifications have provided a strong platform for his research in virology, antimicrobial resistance, and nanoparticle therapeutics, enabling him to bridge fundamental science with applied biomedical solutions. His education has also shaped his teaching and mentorship, fostering future leaders in the microbiology and biomedical fields.

Experience

Dr. Al-Hoot’s professional career spans extensive academic, research, and clinical laboratory roles, reflecting his versatility and leadership in medical microbiology. He has served as an Associate Professor at a reputed Malaysian university, where he has been actively involved in teaching, research supervision, curriculum coordination, and academic leadership. His experience includes managing and leading numerous research projects, both as principal investigator and collaborator, with international partners. Over the years, he has successfully supervised numerous Ph.D. and Master’s students to completion, contributing to global research capacity building. His professional journey also encompasses significant editorial and peer review responsibilities for high-impact scientific journals, ensuring the quality of published research in his field. In addition to his academic work, he has engaged in community outreach, research ethics committees, and scientific event organization. This multifaceted experience underscores his ability to integrate research, teaching, and service for impactful contributions to science and society.

Research Interest

Dr. Al-Hoot’s research interests lie at the intersection of molecular virology, antimicrobial resistance, and innovative therapeutic approaches. He focuses on developing antiviral strategies targeting viral entry and replication, particularly for dengue virus and other significant pathogens. His work explores the use of small interfering RNA (siRNA), synthetic antiviral peptides, and natural products as novel therapeutics. Additionally, he investigates nanoparticle-based antibacterial agents and their role in combating drug-resistant microorganisms. His interests also extend to diagnostic microbiology, infectious diseases, and gut microbiota modulation. By integrating molecular biology techniques with translational applications, Dr. Al-Hoot aims to address global health challenges through innovative, sustainable, and effective solutions. His interdisciplinary research approach fosters collaboration between microbiology, nanotechnology, pharmacology, and clinical sciences, ensuring that his work remains relevant to both scientific advancement and public health needs. These interests continue to guide his projects, publications, and mentorship of emerging researchers in the field.

Awards and Honors

Dr. Al-Hoot’s excellence in research and academia has been recognized through numerous awards and honors. He has received the University of Malaya Excellence Award for his outstanding contributions to scientific research, as well as prestigious scholarships, including the MIS Scholarship during his doctoral studies. His institution has honored him with multiple service excellence recognitions, acknowledging his dedication to teaching, research, and community service. He has been invited as a keynote speaker and panelist at international conferences, reflecting the high regard for his expertise in virology and antimicrobial research. His editorial roles in globally recognized journals and active involvement in peer review further underscore his professional standing. Additionally, his contributions to collaborative projects and research ethics committees have earned him respect within the academic community. These accolades not only celebrate his past achievements but also highlight his continuing commitment to advancing microbiology and immunology for societal benefit.

Research Skills

Dr. Al-Hoot possesses a diverse and advanced skill set in medical microbiology, molecular virology, and infectious disease research. His technical expertise includes RNA interference, synthetic antiviral peptide development, nanoparticle synthesis for antimicrobial applications, molecular diagnostics, and advanced microbiological assays. He is proficient in designing and conducting translational research studies that bridge laboratory findings to clinical applications. His skills extend to grant writing, securing competitive funding, and leading multi-institutional and international research collaborations. In the academic sphere, he excels in curriculum design, postgraduate supervision, and mentorship, fostering the next generation of researchers. His editorial and peer-review experience with high-impact journals demonstrates his ability to critically evaluate scientific work and maintain research integrity. Additionally, his involvement in organizing scientific conferences and workshops highlights his capabilities in knowledge dissemination and community engagement. Collectively, these skills enable him to contribute significantly to both scientific discovery and the broader biomedical research ecosystem.

Publications Top Notes

Title: Autophagy and Senescence: A New Insight in Selected Human Diseases
Authors: P. Rajendran, A.M. Alzahrani, H.N. Hanieh, S.A. Kumar, R. Ben Ammar, M.A. Alhoot, and others
Year: 2019
Citations: 128

Title: Inhibition of Dengue Virus Entry into Target Cells Using Synthetic Antiviral Peptides
Authors: M.A. Alhoot, A.K. Rathinam, S.M. Wang, R. Manikam, S.D. Sekaran
Year: 2013
Citations: 83

Title: Inhibition of Dengue Virus Entry and Multiplication into Monocytes Using RNA Interference
Authors: M.A. Alhoot, S.M. Wang, S.D. Sekaran
Year: 2011
Citations: 70

Title: RNA Interference Mediated Inhibition of Dengue Virus Multiplication and Entry in HepG2 Cells
Authors: M.A. Alhoot, S.M. Wang, S.D. Sekaran
Year: 2012
Citations: 66

Title: Isolation and Screening of Extracellular Protease Enzyme from Fungal Isolates of Soil
Authors: A.M.A. Maitig, M.A.M. Alhoot, K. Tiwari
Year: 2018
Citations: 50

Title: Genetic Diversity of Fungi Producing Mycotoxins in Stored Crops
Authors: F.E.M. Eltariki, K. Tiwari, I.A. Ariffin, M.A. Alhoot
Year: 2018
Citations: 23

Title: An Association between Khat and Diabetes
Authors: A.M. El Hadrani, M.A. Alhoot
Year: 2000
Citations: 23

Title: Climate Change and Health: The Malaysia Scenario
Authors: M.A. Alhoot, W.T. Tong, W.Y. Low, S.D. Sekaran
Year: 2016
Citations: 21

Conclusion

Assoc. Prof. Dr. Mohammed AbdelFatah Mosa Al-Hoot is a distinguished scientist in Medical Microbiology and Immunology, with specialization in Virology and Molecular Microbiology. His research covers molecular virology, antiviral therapeutics, antimicrobial resistance, nanoparticle-based treatments, and infectious diseases, with notable work on dengue virus inhibition through siRNA and antiviral peptides, as well as nanoparticle antibacterials and phytochemical antiviral screening. He holds advanced degrees in medical microbiology and has extensive academic and clinical experience, contributing significantly to education and research. He has led and collaborated on multiple funded projects across several countries, producing over 40 peer-reviewed publications, book chapters, and a patent, with substantial citations. Serving as an editor and reviewer for international journals, he actively advances research quality. His leadership includes curriculum development, postgraduate supervision, ethics committee service, and organizing academic events. Dedicated to mentorship, collaboration, and innovation, he has made impactful contributions to science, capacity building, and the global research community.

Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Prof. Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Professsor at Tabriz University of Medical Sciences, Iran

Prof. Mehdi Yousefi, Associate Professor of Immunology at Tabriz University of Medical Sciences, is a distinguished researcher with an exceptional track record in immunology, reproductive immunology, autoimmune diseases, and cancer immunotherapy. With over a decade of academic and research experience, Prof. Yousefi has published extensively in high-impact journals, earning a Scopus H-index of 58 and a Google Scholar H-index of 71, placing him among the top 1% of highly cited researchers globally. His innovative contributions include several patents on human antibody fragments and advanced biomedical tools, reflecting his strong focus on translational research. Prof. Yousefi has been recognized multiple times as a Top Researcher by Tabriz University of Medical Sciences and has received the prestigious national Razi Award. Through his leadership, collaborative research, and commitment to advancing immunological science, Prof. Yousefi has made significant contributions to both basic and applied biomedical research, enhancing the scientific community’s understanding of immune-related diseases.

Professional Profile 

Education

Prof. Mehdi Yousefi has a strong and distinguished educational background in medical sciences, particularly in immunology. He earned his Bachelor’s degree (B.Sc.) in Medical Laboratory Technology from Tehran University of Medical Sciences in 2004, where he demonstrated academic excellence. He continued his studies at the same university, completing his Master’s degree (M.Sc.) in Immunology in 2007, where he ranked first in the national entrance exam for the program. Building on his passion for immunological research, Prof. Yousefi pursued a PhD in Immunology, also at Tehran University of Medical Sciences, and graduated in 2013 with the highest possible score (20 out of 20). His PhD research focused on humoral immune responses against tetanus toxin at the single-cell level, showcasing his expertise in immunological techniques and innovative approaches to studying immune mechanisms. His consistent academic excellence, top rankings, and commitment to scientific research laid a strong foundation for his successful career in immunology and medical sciences.

Professional Experience

Prof. Mehdi Yousefi has built an impressive professional career rooted in both academic excellence and cutting-edge research. Since 2013, he has served as an academic and research member at the Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, where he currently holds the position of Associate Professor of Immunology. His professional focus spans a wide range of areas, including reproductive immunology, autoimmune diseases, rheumatic disorders, and cancer immunotherapy. Prof. Yousefi has played a pivotal role in mentoring students, leading collaborative research projects, and contributing to the development of advanced immunological diagnostics and therapies. His innovative work has resulted in numerous patents, particularly in the field of antibody fragment development and cancer targeting, demonstrating his ability to bridge fundamental science with clinical applications. Through his leadership, prolific publications, and active participation in the scientific community, Prof. Yousefi has established himself as a respected and influential figure in immunology research.

Research Interest

Prof. Mehdi Yousefi’s research interests focus on understanding the complex mechanisms of the immune system and its role in health and disease. His primary areas of interest include reproductive immunology, where he investigates the immune system’s involvement in pregnancy complications and maternal-fetal tolerance. He also conducts extensive research on autoimmune diseases and rheumatic disorders, aiming to uncover the immunopathological mechanisms driving these conditions to develop more targeted therapies. In addition, Prof. Yousefi has a strong focus on cancer immunotherapy, particularly the development of novel antibody fragments and immunomodulatory approaches for treating cancers such as breast and colorectal cancer. His work also extends to neurosciences, where he explores the immune system’s interactions with the nervous system in neuroinflammatory and neurodegenerative diseases. Through his multidisciplinary approach, combining basic immunology, translational research, and clinical applications, Prof. Yousefi aims to advance immunological knowledge and develop innovative diagnostic and therapeutic strategies for immune-related disorders.

Award and Honor

Prof. Mehdi Yousefi has received numerous prestigious awards and honors, recognizing his outstanding contributions to immunology and biomedical research. He has been repeatedly honored as the Top Researcher at Tabriz University of Medical Sciences in 2014, 2015, 2017, 2020, and 2021, reflecting his consistent excellence in scientific output and impactful research projects. In 2020, he was further recognized at the national level with the prestigious Razi Award, one of the highest honors for medical research in Iran. In 2022, Prof. Yousefi’s global impact was highlighted when he was named among the Top 1% Highly Cited Researchers (ESI), a distinction that underscores the international significance and influence of his publications. These accolades, combined with his numerous patents and his leadership in innovative research projects, demonstrate Prof. Yousefi’s dedication, creativity, and commitment to advancing immunological science, both within Iran and on the global stage.

Research skill

Prof. Mehdi Yousefi possesses a diverse and advanced set of research skills that have enabled him to excel in the fields of immunology, molecular biology, and translational medicine. His expertise includes designing and conducting immunological assays, such as flow cytometry, ELISA, and cell culture techniques, which he applies to study immune responses in conditions ranging from autoimmune diseases to cancer immunotherapy. He has extensive experience in monoclonal antibody development, including phage display technology for the generation of scFv antibody fragments, which has led to several patents. Prof. Yousefi is also skilled in molecular techniques, such as PCR, gene cloning, and gene expression analysis, which he applies to study immune signaling pathways and immune cell interactions. His collaborative approach, combined with strong project management and scientific writing skills, has resulted in numerous high-impact publications and successful research collaborations, making him a well-rounded and innovative researcher in the field of immunology.

Conclusion

His exceptional publication record, high citation impact, consistent institutional and national awards, and innovative patented research make him a top candidate. His breadth of expertise, from immunology to translational medicine, and his proven track record of impactful research across various fields position him strongly for this recognition

Publications Top Noted

  • The effect of vitamin D supplementation and vaginal probiotics on fertility in women with recurrent implantation failure: A randomized clinical trial
    Authors: Badihi E., Sharifi P., Kamrani A., Aghebati-Maleki L., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Impact of lymphocyte immunotherapy (LIT) on fertility rates in recurrent pregnancy loss (RPL) women with antinuclear antibodies: A randomized clinical trial
    Authors: Dashti M., Kamrani A., Shahir-Khajeh Z., Mehdizadeh A., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2025
    Citations: 0

  • Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies
    Authors: Ebrahimi R., Asghari K.M., Alamdary S.J., Hojjat-Farsangi M., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • The role of probiotics in restoring the Th1 to Th2 ratio in women experiencing recurrent implantation failure; a double-blind randomized clinical trial
    Authors: Kamrani A., Asghari K.M., Zafarani Y., Zolfaghari M.A., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Investigating the effect of echinacea extraction syrup on the outcomes of lower respiratory infections in patients with COVID-19: a randomized clinical trial study
    Authors: Kheirandish E., Mahdizadeh M., Mahdizadeh M., Yousefi M., Shojaee S.S.R.
    Journal: Virology Journal
    Year: 2024
    Citations: 0

  • Cyclosporine and fedratinib combination therapy via modulating Th17/Treg balance in Rat model of membranous glomerulonephritis
    Authors: Ghassabi A., Hosseini M., Abdoli Goungormaz H., Etemadi J., Yousefi M.
    Journal: Biochemistry and Biophysics Reports
    Year: 2024
    Citations: 0

  • The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
    Authors: Sadeghi M., Moslehi A., Kheiry H., Movassaghpuor A.A., Niaragh F.J.
    Journal: Cancer Cell International
    Year: 2024
    Citations: 2

  • Evaluation of changes in exhausted T lymphocytes and miRNAs expression in the different trimesters of pregnancy in pregnant women
    Authors: Shekarchi A.A., Hosseini L., Kamrani A., Ahmadian Heris J., Yousefi M.
    Journal: Molecular Biology Reports
    Year: 2024
    Citations: 0

  • Revolutionized attitude toward recurrent pregnancy loss and recurrent implantation failure based on precision regenerative medicine
    Authors: Asghari K.M., Novinbahador T., Mehdizadeh A., Zolfaghari M.A., Yousefi M.
    Journal: Heliyon
    Year: 2024
    Citations: 0

  • Analysis of Th17 cell population and expression of microRNA and factors related to Th17 in patients with premature ovarian failure
    Authors: Nouri N., Aghebati-Maleki L., Zangbar M.S.S., Chakari-Khiavi F., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2024
    Citations: 2

Hua Jin | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Ms. Hua Jin | Immunology and Microbiology | Best Researcher Award

Research Assistant at Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, China

Ms. Hua Jin is a highly accomplished researcher in hepatology and immunology. She holds an M.B. in clinical medicine and advanced degrees (M.S. and M.D.) in hepatology from Capital Medical University and Beijing Friendship Hospital, China. Currently, she works as a researcher at the Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital. Her research focuses on liver injury and immune responses, particularly the role of OX40 in hepatic ischemia-reperfusion injury and drug-induced liver damage. She has co-authored numerous high-impact publications in journals like JCI Insight, British Journal of Pharmacology, and Cell Reports. Her groundbreaking work has earned her recognition, including the prestigious American Transplant Congress Young Investigator Award in 2021. In addition to her research, she has presented her findings at major international conferences, including the Asian Pacific Association for the Study of the Liver and the American Transplant Congress.

Professional Profile

Education

Ms. Hua Jin has a strong academic background in clinical medicine and hepatology. She completed her undergraduate studies in Clinical Medicine at Chongqing Medical University in China, earning her M.B. degree from 2009 to 2014. Following this, she pursued advanced training in hepatology, earning her M.S. degree from the Experimental and Translational Research Center at Beijing Friendship Hospital, Capital Medical University, from 2015 to 2018. Building on this foundation, she furthered her expertise by obtaining an M.D. in hepatology, also from the Experimental and Translational Research Center, between 2018 and 2021. This rigorous education provided Ms. Jin with a deep understanding of both clinical and research aspects of hepatology, setting the stage for her current work in immunology and liver disease. Her academic achievements reflect a commitment to advancing knowledge in medical research, particularly in the areas of liver injury and immune system regulation.

Professional Experience

Ms. Hua Jin has extensive professional experience in the field of medical research, particularly in hepatology and immunology. After completing her advanced degrees, she began her research career as a Research Assistant at the Immunology Research Center for Oral and Systemic Health at Beijing Friendship Hospital, Capital Medical University, from 2021 to 2024. During this time, she worked on critical research related to immune responses in liver injury, with a focus on the role of OX40 in liver diseases. In 2024, she transitioned to her current role at the Medical Research Center, Beijing Institute of Respiratory Medicine, and Beijing Chao-Yang Hospital, where she continues her work in hepatology and immunology. Throughout her career, Ms. Jin has contributed to numerous high-impact research projects, authored multiple publications in prestigious journals, and presented her work at leading international conferences, establishing herself as a promising young investigator in the field of liver disease and immune system regulation.

Research interest

Ms. Hua Jin’s research interests primarily focus on hepatology, immunology, and liver diseases. Her work investigates the immune mechanisms underlying liver injury, particularly the role of immune checkpoints like OX40 in hepatic ischemia-reperfusion injury, drug-induced liver injury, and non-alcoholic steatohepatitis (NASH). She is particularly interested in how immune responses, both innate and adaptive, contribute to liver diseases, aiming to identify potential therapeutic targets for improving liver function and preventing damage. Her research also delves into the cellular and molecular dynamics of immune cells such as neutrophils and T cells in liver injury. Through the application of advanced techniques like single-cell transcriptomics, she explores the heterogeneity of immune cell populations and their roles in inflammation and liver repair. Ms. Jin’s work seeks to bridge the gap between basic immunology and clinical hepatology, with the goal of developing novel, immune-based therapeutic strategies for liver diseases.

Award and Honor

Ms. Hua Jin has received notable recognition for her research contributions, highlighting her prominence in the fields of hepatology and immunology. In 2021, she was honored with the prestigious American Transplant Congress Young Investigator Award, which acknowledges exceptional young researchers making significant strides in transplant medicine and immunology. This award reflects the high regard her work has garnered within the scientific community. Additionally, Ms. Jin has published multiple influential papers in top-tier journals, such as JCI Insight, Cell Reports, and British Journal of Pharmacology, further cementing her status as a rising star in medical research. Her innovative studies on immune responses in liver injury and the role of immune checkpoints like OX40 have gained widespread recognition. Furthermore, she has presented her research at prominent international conferences, including the Asian Pacific Association for the Study of the Liver and American Transplant Congress, showcasing her contributions to the global medical research community.

Conclusion

Hua Jin demonstrates the core qualities of an outstanding researcher: academic excellence, groundbreaking contributions, and recognition within his field. His work on immune responses in liver injury is cutting-edge and contributes valuable insights to the medical community. With continued growth in his research portfolio and a potential increase in his mentorship and international networking, he could further enhance his impact. Based on these strengths, Hua Jin is highly deserving of consideration for the Best Researcher Award.

Publications Top Noted

  • “Rebalancing liver-infiltrating CCR3+ and CD206+ monocytes improves diet-induced NAFLD”
    • Authors: Sun, G., Wang, Y., Yang, L., Zhang, Z., Zhang, D.
    • Year: 2023
    • Citations: 5
  • Erratum to “Isolation and purification of immune cells from the liver”
    • Authors: Shi, W., Wang, Y., Zhang, C., Zhang, D., Sun, G.
    • Year: 2023
    • Citations: 0
  • “OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis”
    • Authors: Xu, L., Tian, D., Zhou, M., Zhang, D., Wu, J.
    • Year: 2022
    • Citations: 2
  • “Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis”
    • Authors: Chen, S., Lv, T., Sun, G., Zhang, D., Jia, J.
    • Year: 2022
    • Citations: 6
  • “The Critical and Diverse Roles of CD4–CD8– Double Negative T Cells in Nonalcoholic Fatty Liver Disease”
    • Authors: Li, C., Du, X., Shen, Z., Zhang, D., Sun, G.
    • Year: 2022
    • Citations: 11
  • “CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis”
    • Authors: Sun, G., Zhao, X., Li, M., Zhang, Z., Zhang, D.
    • Year: 2021
    • Citations: 22
  • “Transcriptome landscape of double negative T cells by single-cell RNA sequencing”
    • Authors: Yang, L., Zhu, Y., Tian, D., Zhao, Y., Zhang, D.
    • Year: 2021
    • Citations: 26
  • “Dietary Inorganic Nitrate Protects Hepatic Ischemia-Reperfusion Injury Through NRF2-Mediated Antioxidative Stress”
    • Authors: Li, S., Jin, H., Sun, G., Zhang, D., Wang, S.
    • Year: 2021
    • Citations: 14
  • “Isolation and purification of immune cells from the liver”
    • Authors: Shi, W., Wang, Y., Zhang, C., Zhang, D., Sun, G.
    • Year: 2020
    • Citations: 34
  • “Critical role of OX40 in drug-induced acute liver injury”
    • Authors: Zhang, C., Jin, H., Wang, Y., Sun, G., Zhang, D.
    • Year: 2020
    • Citations: 4

 

Rancés Blanco Santana | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Dr. Rancés Blanco Santana | Immunology and Microbiology | Best Researcher Award

Researcher at Independent, Chile

Dr. Rancés Blanco Santana is an accomplished Cuban researcher with extensive expertise in oncology, molecular biology, and histopathology. His work primarily focuses on understanding the interplay between oncogenic viruses such as Epstein-Barr Virus (EBV) and Human Papillomavirus (HPV) and their role in carcinogenesis, particularly in head and neck, cervical, and breast cancers. With a prolific publication record of over 30 peer-reviewed articles in high-impact journals, Dr. Blanco has significantly contributed to advancing knowledge in cancer biomarkers, therapeutic targets, and the mechanisms of environmental carcinogens. His career spans over 15 years of impactful research, including international collaborations and independent studies. He is currently based in Santiago, Chile, where he continues to lead cutting-edge cancer research. Dr. Blanco’s dedication to biomedical science, combined with his ability to address complex health challenges, establishes him as a leading figure in his field.

Professional profile

Education📚

Dr. Blanco Santana has a robust academic foundation in health sciences. He earned his Bachelor’s in Health Technology (specializing in Cytohistopathology) from the Higher Institute of Medical Sciences in Havana, Cuba, in 2007. He later obtained a Diploma in Histology from the Institute of Basic and Preclinical Sciences “Victoria de Girón” in 2008. His commitment to advancing his expertise culminated in earning a Ph.D. in Health Sciences from the University of Medical Sciences of Havana in 2017. These credentials underscore his deep theoretical and practical knowledge in cancer biology and histological techniques. His academic training has been instrumental in shaping his career as a researcher and in conducting translational studies that address critical issues in cancer diagnostics and treatment.

Professional Experience🏛️

Dr. Blanco’s career spans a diverse range of roles across esteemed institutions. Currently, he is an Independent Researcher in Santiago, Chile (2022–present). Previously, he was a Postdoctoral Research Assistant at the Laboratory of Molecular Oncovirology, University of Chile (2019–2022), where he focused on the molecular mechanisms of viral carcinogenesis. His earlier tenure at the Center of Molecular Immunology in Havana, Cuba, involved roles as a Postdoctoral Research Assistant (2017–2019), an Associate Researcher (2007–2017), and a Quality Control Specialist (2007–2019). These experiences highlight his expertise in cancer immunology, therapeutic antibody development, and quality control. His ability to adapt to multidisciplinary teams and environments has been a hallmark of his professional growth.

Research Interest🌐

Dr. Blanco’s research interests lie at the intersection of viral oncology and molecular carcinogenesis. He explores how oncogenic viruses like EBV and HPV interact with environmental factors, such as tobacco smoke, to drive cancer progression. His studies on co-infections in head and neck cancers, cervical lesions, and breast cancer have provided insights into the molecular pathways involved, including oxidative stress, DNA damage, and immune evasion. He is particularly interested in identifying biomarkers and novel therapeutic targets to improve cancer diagnosis and treatment. Dr. Blanco’s research also extends to the study of tumor microenvironments, monoclonal antibody therapies, and the role of oxidative stress sensors in epithelial malignancies, reflecting his commitment to addressing complex biomedical challenges.

Awards and Honors🏆

Although specific awards and honors are not explicitly detailed in the provided information, Dr. Blanco’s contributions to cancer research and his extensive publication record position him as a prominent researcher deserving of recognition. His achievements have likely earned him informal accolades and professional respect in his field. Notably, his selection for postdoctoral roles at prestigious institutions, such as the University of Chile, is a testament to his expertise and leadership in molecular oncology. Further acknowledgment of his work through formal awards would serve to highlight the significant impact of his research on cancer biology and therapeutic innovation.

Conclusion

Dr. Rancés Blanco Santana stands out as a strong candidate for the Best Researcher Award due to his profound contributions to oncology research, extensive publication record, and ability to work across disciplines and geographic regions. Enhancing his leadership profile and visibility in global scientific forums would further solidify his candidacy. Overall, his qualifications and achievements make him highly deserving of this recognition.

Publications top noted📜
  • Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody
    Authors: G. Garrido, A. Rabasa, B. Sánchez, M.V. López, R. Blanco, A. López, …
    Year: 2011
    Citations: 108
  • Biological Activity In Vitro of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies with Different Affinities
    Authors: A. Diaz Miqueli, R. Blanco, B. Garcia, T. Badia, A.E. Batista, R. Alonso, …
    Year: 2007
    Citations: 67
  • Immunoreactivity of the 14F7 Mab (raised against N‐Glycolyl GM3 Ganglioside) as a positive prognostic factor in non‐small‐cell lung cancer
    Authors: R. Blanco, C.E. Rengifo, M. Cedeno, M. Frometa, E. Rengifo, A. Carr
    Year: 2012
    Citations: 56
  • Immunoreactivity of the 14F7 Mab raised against N‐Glycolyl GM3 ganglioside in epithelial malignant tumors from digestive system
    Authors: R. Blanco, E. Rengifo, M. Cedeño, C.E. Rengifo, D.F. Alonso, A. Carr
    Year: 2011
    Citations: 52
  • Prognostic significance of N‐glycolyl GM3 ganglioside expression in non‐small cell lung carcinoma patients: New evidences
    Authors: R. Blanco, E. Domínguez, O. Morales, D. Blanco, D. Martínez, C.E. Rengifo, …
    Year: 2015
    Citations: 45
  • Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N‐Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms
    Authors: R. Blanco, E. Rengifo, C.E. Rengifo, M. Cedeno, M. Frometa, A. Carr
    Year: 2011
    Citations: 41
  • High-risk human papillomavirus and tobacco smoke interactions in epithelial carcinogenesis
    Authors: F. Aguayo, J.P. Muñoz, F. Perez-Dominguez, D. Carrillo-Beltrán, C. Oliva, …
    Year: 2020
    Citations: 38
  • Human antibodies reactive to NeuGc GM3 ganglioside have cytotoxic antitumor properties
    Authors: N. Rodríguez‐Zhurbenko, D. Martínez, R. Blanco, T. Rondón, T. Griñán, …
    Year: 2013
    Citations: 37
  • Tissue Reactivity of the 14F7 Mab Raised against N‐Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin
    Authors: R. Blanco, Y. Quintana, D. Blanco, M. Cedeño, C.E. Rengifo, M. Frómeta, …
    Year: 2013
    Citations: 29
  • Role of Epstein-Barr virus and human papillomavirus coinfection in cervical cancer: epidemiology, mechanisms and perspectives
    Authors: R. Blanco, D. Carrillo-Beltrán, J.C. Osorio, G.M. Calaf, F. Aguayo
    Year: 2020
    Citations: 26
  • Role of Pirin, an Oxidative Stress Sensor Protein, in Epithelial Carcinogenesis
    Authors: A.F. Perez-Dominguez, D. Carrillo-Beltrán, R. Blanco, J.P. Muñoz, G. León-Cruz, …
    Year: 2021
    Citations: 24
  • Immunoreactivity of the 14F7 Mab Raised against N‐Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis
    Authors: R. Blanco, D. Blanco, Y. Quintana, X. Escobar, C.E. Rengifo, M. Osorio, …
    Year: 2013
    Citations: 24
  • Immunorecognition of the 14F7 Mab Raised against N‐Glycolyl GM3 Ganglioside in Some Normal and Malignant Tissues from Genitourinary System
    Authors: R. Blanco, M. Cedeño, X. Escobar, D. Blanco, C.E. Rengifo, M. Frómeta, …
    Year: 2011
    Citations: 24
  • High-Risk Human Papillomavirus and Epstein–Barr Virus Coinfection: A Potential Role in Head and Neck Carcinogenesis
    Authors: R. Blanco, D. Carrillo-Beltrán, A.H. Corvalán, F. Aguayo
    Year: 2021
    Citations: 23
  • Human papillomavirus 16 E7 promotes EGFR/PI3K/AKT1/NRF2 signaling pathway contributing to PIR/NF-κB activation in oral cancer cells
    Authors: D. Carrillo-Beltrán, J.P. Muñoz, N. Guerrero-Vásquez, R. Blanco, O. León, …
    Year: 2020
    Citations: 23

Yan Pan | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Mr. Yan Pan | Immunology and Microbiology | Best Researcher Award

Medical team leader at The First Affiliated Hospital of Yangtze University, China

Dr. Yan Pan is a distinguished Deputy Chief Physician of Pediatrics at the First Affiliated Hospital of Yangtze University, specializing in Kawasaki disease. With a master’s degree and extensive clinical experience, he is dedicated to improving pediatric care and outcomes through innovative research. Dr. Pan has authored 10 SCI articles as the first or corresponding author, significantly advancing the understanding of pediatric infections and immunology. His leadership in multidisciplinary research and contributions to national treatment guidelines reflect his commitment to clinical excellence. Recognized with multiple awards, including the 2023 “Best Researcher” award in pediatric infection and immunity, he is also a Fellow of the Royal Society of Arts and Crafts. As Deputy Editor in Chief of the International Journal of Pediatrics, Dr. Pan actively shapes academic discourse. He is passionate about mentoring future pediatric specialists and aims to enhance treatment strategies for pediatric immune-related conditions on both national and international levels.

Professional profile

Education📚

Dr. Yan Pan holds a master’s degree in medicine, which has laid the foundation for his extensive career in pediatrics. His academic journey began with a strong focus on pediatric medicine, where he developed a keen interest in Kawasaki disease and its treatment. Throughout his education, Dr. Pan engaged in rigorous clinical training and research, equipping him with the skills necessary to diagnose and manage complex pediatric conditions effectively. His commitment to lifelong learning is evident in his ongoing participation in professional development and research initiatives. This dedication has not only enhanced his knowledge and expertise but has also allowed him to contribute significantly to national treatment guidelines and multidisciplinary research projects. Dr. Pan’s educational background, coupled with his clinical experience, has positioned him as a leading expert in pediatric care, making him a valuable asset to both his institution and the broader medical community.

Professional Experience🏛️

Dr. Yan Pan serves as the Deputy Chief Physician of Pediatrics at the First Affiliated Hospital of Yangtze University, where he specializes in the diagnosis and treatment of Kawasaki disease. With years of clinical experience, he has made significant contributions to pediatric care, focusing on improving treatment protocols and patient outcomes. Dr. Pan leads the Kawasaki Disease Multidisciplinary Team (MDT), coordinating efforts among healthcare professionals to enhance collaborative care. He has been instrumental in compiling national treatment guidelines, reflecting his commitment to advancing pediatric healthcare practices. Additionally, he has authored 10 SCI articles, earning recognition for his research in pediatric infection and immunity. His leadership extends to roles such as Deputy Editor in Chief of the International Journal of Pediatrics, where he guides academic discourse and publication quality. Through mentoring and involvement in various research initiatives, Dr. Pan continues to shape the future of pediatric medicine, striving for excellence in both clinical practice and research.

Research Interest🌐

Dr. Yan Pan’s primary research interest lies in Kawasaki disease, a complex pediatric condition that poses significant challenges in diagnosis and treatment. He is dedicated to advancing the understanding of this disease through innovative research, aiming to improve clinical outcomes for affected children. His work focuses on enhancing treatment protocols to reduce long-term complications associated with Kawasaki disease, integrating evidence-based strategies into clinical practice. Additionally, Dr. Pan is passionate about pediatric immunology and infection control, exploring the underlying mechanisms of immune responses in children and their implications for treatment. He actively engages in multidisciplinary research projects, fostering international collaborations to address unmet clinical needs in pediatric care. Through his publications and presentations at international conferences, Dr. Pan contributes to the global discourse on pediatric health, aiming to develop more effective therapeutic strategies and establish comprehensive treatment guidelines that benefit both national and international pediatric communities.

Awards and Honors🏆

Dr. Yan Pan has received numerous awards and honors recognizing his outstanding contributions to pediatric medicine and research. Notably, he was awarded the prestigious “Best Researcher” award in pediatric infection and immunity in 2023, highlighting his impactful work in this critical area. His excellence in research has also earned him the “Best Outstanding Paper of the Year” award from the Discussion of Clinical Cases Magazine in the same year, showcasing his commitment to advancing knowledge in pediatric care. As a Fellow of the Royal Society of Arts and Crafts, Dr. Pan has been acknowledged for his contributions to the field and his role in shaping healthcare practices. Furthermore, he serves as an expert member of the China National Knowledge Infrastructure (CNKI) Evaluation Expert Database, underscoring his influence in the academic community. Through his leadership and dedication, Dr. Pan continues to inspire peers and future generations of pediatricians, solidifying his reputation as a leader in his field.

Conclusion

In conclusion, Dr. Pan Yan’s extensive qualifications, demonstrated leadership, impactful research, and commitment to improving pediatric healthcare make him an outstanding candidate for the Best Researcher Award. His focus on Kawasaki disease not only exemplifies a dedication to a vital area of pediatric health but also highlights his contributions to clinical practice and research advancements. With a solid foundation in mentorship and collaborative work, Dr. Yan is poised to continue making significant strides in pediatric medicine, making him a worthy recipient of this prestigious award.

Publications top noted📜
  • Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China
    • Authors: Jiao, F., Pan, Y., Du, Z., Gao, C., Bai, J.
    • Year: 2024
    • Citations: 0
  • Link between childhood obesity and gut microbiota
    • Authors: Pan, Y., Jiao, F.-Y.
    • Year: 2024
    • Citations: 0
  • Treatment of immunoglobulin-resistant Kawasaki disease: a Bayesian network meta-analysis of different regimens
    • Authors: Pan, Y., Fan, Q., Hu, L.
    • Year: 2023
    • Citations: 8
  • Angiotensin-converting enzyme 2 G8790A polymorphisms are associated with COVID-19 severity
    • Authors: Pan, Y.
    • Year: 2023
    • Citations: 1
  • A nomogram for predicting immunoglobulin-resistant Kawasaki disease in children
    • Authors: Pan, Y., Fan, Q.
    • Year: 2023
    • Citations: 0
  • Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and the Risk of COVID-19: A Meta-Analysis
    • Authors: Luoyi, H., Yan, P., Qihong, F.
    • Year: 2023
    • Citations: 2
  • Angiotensin-converting enzyme insertion/deletion gene polymorphism and Henoch-Schonlein purpura nephritis risk in children: a meta-analysis
    • Authors: Yan, P., Xu, S.
    • Year: 2023
    • Citations: 0
  • Clostridium Symbiosum Sepsis Diagnosed Using Next-Generation Sequencing in a 2 Year Old Child: A Case Report
    • Authors: Pan, Y., Fan, Q.
    • Year: 2023
    • Citations: 1
  • The Role of Procalcitonin for Predicting Kawasaki Disease
    • Authors: Pan, Y., Fan, Q.
    • Year: 2022
    • Citations: 1
  • Anal swab findings in an infant with COVID-19
    • Authors: Fan, Q., Pan, Y., Wu, Q., Guan, L., Lv, X.
    • Year: 2020
    • Citations: 36

Tae Heung Kang | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Dr. Tae Heung Kang | Immunology and Microbiology | Best Researcher Award

Director at Prestige Biopharma IDC, South Korea

Dr. Tae Heung Kang is a distinguished scientist and Director at Prestige Biopharma IDC, South Korea, known for his groundbreaking research in cancer immunotherapy and immunomodulation. With over 15 years of experience, he has held significant roles at prestigious institutions, including Johns Hopkins University and Konkuk University. Dr. Kang’s work focuses on enhancing immune responses to cancer, with notable achievements such as developing therapeutic nanogels and immune checkpoint inhibitors. His prolific research output includes high-impact publications in top journals like Nature Communications and Biomaterials, reflecting the global impact of his work in oncology. As a corresponding author on numerous studies, Dr. Kang demonstrates strong leadership and expertise in immunology. Through his innovative approach, he is driving advances in targeted cancer treatments, contributing both to scientific understanding and potential clinical applications, marking him as a prominent figure in biomedical research and a deserving candidate for the Best Researcher Award.

Professional profile

Education📚

Dr. Tae Heung Kang has a solid academic foundation in biotechnology and genetic engineering, with degrees from prominent institutions in South Korea. He earned his Ph.D. in Biotechnology from Chonnam National University (2000–2005), focusing on advanced biotechnological approaches that laid the groundwork for his future research in cancer immunology. Prior to this, he completed his Master’s degree in Biotechnology at Korea University (1997–1999), where he developed foundational expertise in molecular biology and biotechnological applications. Dr. Kang began his academic journey with a Bachelor’s degree in Genetic Engineering from Chonnam National University (1991–1997), building a robust understanding of genetic sciences and bioengineering. His comprehensive educational background provided him with a deep understanding of biotechnology and genetics, equipping him with the skills essential for his pioneering work in cancer immunotherapy and immunomodulation. This extensive training in biotechnology underpins his impactful research and leadership in the biomedical field.

Professional Experience🏛️

Dr. Tae Heung Kang is a seasoned biomedical researcher with over 15 years of experience in cancer immunotherapy and immunomodulation. Currently, he serves as the Director of Prestige Biopharma IDC, where he leads research in innovative cancer treatments. Prior to this role, he was the Chief Researcher at Prestige Biopharma, demonstrating his rapid advancement and trusted expertise in the organization. His academic experience includes nearly a decade as an Assistant Professor in the School of Medicine at Konkuk University, where he contributed to biomedical research and mentored future scientists. Dr. Kang also gained international research experience as a Postdoctoral Fellow in Pathology at Johns Hopkins University, a role that deepened his expertise in molecular cancer biology. His career began with roles at Korea University as a Postdoctoral Fellow and Research Professor, providing him with a strong foundation in biotechnology and research leadership that continues to drive his impactful work in cancer immunology.

Research Interest🌐

Dr. Tae Heung Kang’s research interests lie in the fields of cancer immunotherapy, immunomodulation, and targeted cancer treatments. His work focuses on enhancing the body’s immune response to combat cancer, with a particular emphasis on novel therapeutic approaches such as immune checkpoint inhibitors and nanocarrier systems. Dr. Kang explores how tumor microenvironments and immune cells interact, aiming to develop treatments that transform the body’s immune defenses to more effectively recognize and destroy cancer cells. His studies include the use of biomaterials and innovative techniques like antigenic peptide conjugates, which improve the precision and potency of immune-based therapies. He is also invested in understanding the molecular pathways involved in immune responses to tumors, including the roles of proteins like annexin and TLR-binding molecules. By advancing these areas, Dr. Kang’s research holds promise for groundbreaking treatments in oncology, with potential applications in clinical cancer care and patient outcomes.

Awards and Honors🏆

Dr. Tae Heung Kang has earned significant recognition throughout his career for his contributions to cancer immunotherapy and biomedical research. Although specific awards and honors are not listed in the available information, his prestigious roles and publication record in high-impact journals speak to his respected standing in the scientific community. Dr. Kang’s research has been featured in top journals, including Nature Communications and Biomaterials, an indication of both the impact and quality of his work. His leadership as Director of Prestige Biopharma IDC, along with his former roles as Chief Researcher and Assistant Professor, reflect the trust placed in his expertise by academic and research institutions. These accomplishments collectively suggest Dr. Kang’s role as an innovator in oncology research, likely accompanied by professional accolades that underscore his ongoing commitment to advancing cancer treatment and immunotherapy methods, positioning him as a leader in his field.

Conclusion

Dr. Tae Heung Kang is a strong candidate for the Best Researcher Award, with a proven record of innovative research and publications that have significantly contributed to cancer immunotherapy. His leadership at Prestige Biopharma IDC, coupled with his impactful scientific contributions, align well with the award’s emphasis on research excellence. By enhancing interdisciplinary collaborations, securing additional project funding, and documenting his mentorship contributions, Dr. Kang can further bolster his already impressive profile, making him even more competitive for this esteemed recognition.

Publications top noted📜
  • “Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer”
    • Authors: Lee, S.E., Jang, G.-Y., Lee, J., Park, Y.-M., Kang, T.H.
    • Year: 2022
    • Citations: 13
  • “PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway”
    • Authors: Youn, S.E., Jiang, F., Won, H.Y., Park, Y.-Y., Koh, S.S.
    • Year: 2022
    • Citations: 5
  • “Enhancement of anticancer immunity by immunomodulation of apoptotic tumor cells using annexin A5 protein-labeled nanocarrier system”
    • Authors: Lee, S.E., Lee, C.M., Won, J.E., Han, H.D., Park, Y.-M.
    • Year: 2022
    • Citations: 10
  • “Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches”
    • Authors: Won, J.E., Byeon, Y., Wi, T.I., Park, Y.-M., Han, H.D.
    • Year: 2022
    • Citations: 12
  • “A novel form of immunotherapy using antigen peptides conjugated on PD-L1 antibody”
    • Authors: Lee, E.J., Jang, G.-Y., Lee, S.E., Park, Y.-M., Kang, T.H.
    • Year: 2021
    • Citations: 6
  • “NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer”
    • Authors: Won, J.E., Wi, T.I., Lee, C.M., Park, Y.-M., Han, H.D.
    • Year: 2021
    • Citations: 26
  • “Targeted tumor coating with antigenic, CTL-recognizable peptides via Annexin A5 chimeric constructs following chemotherapy redirects adaptive CD8+ T cell immunity for tumor clearance”
    • Authors: Kang, T.H., Yang, A., Tsai, Y., Ferrall, L., Hung, C.-F.
    • Year: 2021
    • Citations: 3
  • “Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors”
    • Authors: Jang, G.-Y., Kim, Y.S., Lee, S.E., Kang, T.H., Park, Y.-M.
    • Year: 2021
    • Citations: 17
  • “Interactions between tumor-derived proteins and Toll-like receptors”
    • Authors: Jang, G.-Y., Lee, J., Kim, Y.S., Kang, T.H., Park, Y.-M.
    • Year: 2020
    • Citations: 54
  • “Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment”
    • Authors: Kang, T.H., Park, J.H., Yang, A., Park, Y.-M., Hung, C.-F.
    • Year: 2020
    • Citations: 53

Kazim Şahin | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Mr. Kazim Şahin | Immunology and Microbiology | Best Researcher Award

Associate Professor at Recep Tayyip Erdogan University, Turkey

Mr. Kazım Şahin, born on October 16, 1960, in Malatya, Turkey, is a dedicated researcher and educator in Basic Medicine and Medical Microbiology at Recep Tayyip Erdogan University Faculty of Medicine since July 2009. He earned his medical degree from Istanbul University and furthered his education at Inonu University. Mr. Şahin has actively contributed to the scientific community through numerous published articles in both international and national journals, showcasing his commitment to advancing research in his field. His extensive experience in academia positions him as a mentor for students, fostering the next generation of researchers. While his achievements are commendable, there is potential for growth in enhancing the visibility of his research and pursuing further professional development. Overall, Mr. Şahin’s dedication to medical education and research makes him a valuable asset in the scientific community, underscoring his candidacy for recognition through awards such as the Best Researcher Award.

Professional profile

Education📚

Mr. Kazım Şahin’s educational journey reflects his commitment to the field of medicine and medical microbiology. He began his academic path at Istanbul University, where he completed his medical degree from the Istanbul Faculty of Medicine between 1978 and 1984. This foundational education provided him with essential knowledge and skills in medicine. Following this, Mr. Şahin continued his education at Inonu University from 1995 to 2000, further enhancing his expertise in the medical sciences. This advanced training allowed him to delve deeper into specialized areas of medical microbiology, laying the groundwork for his subsequent career as a researcher and educator. His educational background not only equipped him with a solid understanding of medical principles but also positioned him to contribute significantly to research and academic discourse in his field. Overall, Mr. Şahin’s education underscores his dedication to lifelong learning and professional development in medicine.

Professional Experience🏛️

Mr. Kazım Şahin has built a distinguished career in the field of medicine, specifically in Basic Medicine and Medical Microbiology. Since July 2009, he has been serving as a faculty member at Recep Tayyip Erdogan University Faculty of Medicine, where he has contributed significantly to both teaching and research. His role involves educating medical students, guiding research projects, and mentoring future healthcare professionals, showcasing his commitment to academic excellence and student development. Throughout his tenure, Mr. Şahin has also engaged in various research activities, resulting in numerous publications in both international and national journals, reflecting his active involvement in advancing medical knowledge. His extensive experience in academia, coupled with his focus on medical microbiology, positions him as a respected authority in his field. By bridging the gap between research and education, Mr. Şahin plays a crucial role in shaping the next generation of medical practitioners and researchers.

Research Interest🌐

Mr. Kazım Şahin’s research interests lie primarily in the fields of Basic Medicine and Medical Microbiology. His work focuses on understanding microbial pathogenesis, exploring the mechanisms by which pathogens cause disease, and investigating their interactions with host immune responses. He aims to advance knowledge in infectious diseases, contributing to the development of effective diagnostic tools and therapeutic strategies. Additionally, Mr. Şahin is interested in the role of microbiomes in health and disease, examining how microbial communities influence human physiology and contribute to various medical conditions. His research endeavors are underscored by a commitment to improving clinical practices and enhancing patient care through scientific inquiry. By publishing in both national and international journals, he shares his findings with the broader medical community, fostering collaboration and knowledge exchange. Overall, Mr. Şahin’s research interests reflect his dedication to addressing critical challenges in medical microbiology and improving public health outcomes.

Awards and Honors🏆

Mr. Kazım Şahin has garnered recognition for his contributions to the field of medicine and medical microbiology throughout his academic career. While specific details of awards and honors may not be available, his extensive publication record in both international and national journals highlights his commitment to research excellence and impactful contributions to medical science. Such publications often reflect his influence within the academic community and his dedication to advancing knowledge in his field. Additionally, Mr. Şahin’s role as an educator at Recep Tayyip Erdogan University Faculty of Medicine demonstrates his commitment to mentoring future healthcare professionals, further emphasizing his impact on medical education. The respect he has earned from colleagues and students alike is a testament to his professional integrity and dedication to his work. Through his ongoing research and teaching efforts, Mr. Şahin continues to foster a culture of academic achievement and innovation, contributing to the recognition of his work in the medical community.

Conclusion

Kazım Şahin has demonstrated considerable strengths as a researcher through his extensive experience, solid educational background, and contributions to published literature. While there are areas for improvement, particularly in enhancing the visibility of his research and engaging in continued professional development, these can be addressed through proactive measures. Given his current accomplishments and potential for growth, he is a strong candidate for the Best Researcher Award. His dedication to medical education and research makes him a valuable asset to the scientific community, and recognition through this award could further motivate his contributions.

Publications top noted📜
  • Title: The impact of magnesium biotinate and arginine silicate complexes on metabolic dysfunctions, antioxidant activity, inflammation, and neuromodulation in high-fat diet-fed rats
    Authors: Sahin, K., Sahin, E., Orhan, C., … Sahin, N., Komorowski, J.R.
    Year: 2024
    Citation: Clinical and Experimental Medicine, 24(1), 176
  • Title: Chitosan-Coated Scorpion Venom Ameliorates Acute Lung Injury Caused by Klebsiella Pneumoniae
    Authors: Oskay, B., Sahin, K., Caliskan, F., … Karakas, S.M., Yazici, Z.A.
    Year: 2024
    Citation: International Journal of Peptide Research and Therapeutics, 30(5), 54
  • Title: Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model
    Authors: Sahin, K., Gencoglu, H., Korkusuz, A.K., … Padigaru, M., Kilic, E.
    Year: 2024
    Citation: Antioxidants, 13(6), 657
  • Title: Understanding Cr(III) Action on Mitochondrial ATP Synthase and AMPK Efficacy: Insights from Previous Studies—a Review
    Authors: Gencoglu, H., Orhan, C., Sahin, K.
    Year: 2024
    Citation: Biological Trace Element Research, 202(4), pp. 1325–1334
  • Title: Effects of Whey Protein Combined with Amylopectin/Chromium on the Muscle Protein Synthesis and mTOR Phosphorylation in Exercised Rats
    Authors: Sahin, K., Orhan, C., Ozdemir, O., … Ojalvo, S.P., Komorowski, J.R.
    Year: 2024
    Citation: Biological Trace Element Research, 202(3), pp. 1031–1040
  • Title: Novel formulations ameliorate osteoarthritis in rats by inhibiting inflammation and oxidative stress
    Authors: Erten, F., Ozdemir, O., Tokmak, M., … Padigaru, M., Sahin, K.
    Year: 2024
    Citation: Food Science and Nutrition
  • Title: Impact of the arginine silicate inositol complex on bone metabolism in broiler chickens with tibial dyschondroplasia caused by manganese deficiency
    Authors: Sahin, E., Ipcak, H.H., Orhan, C., … Balci, T.A., Sahin, K.
    Year: 2024
    Citation: British Poultry Science, 65(4), pp. 455–464
  • Title: Beneficial effects of a novel polyherbal formulation on the skeletal muscle antioxidant status, inflammation, and muscle-signaling proteins in exercised rats
    Authors: Tuzcu, M., Özdemir, O., Orhan, C., … Bhanuse, P., Şahin, K.
    Year: 2024
    Citation: Turkish Journal of Biology, 48(1), pp. 59–69
  • Title: A highly bioavailable curcumin formulation ameliorates inflammation cytokines and neurotrophic factors in mice with traumatic brain injury
    Authors: Sakul, A.A., Balcikanli, Z., Ozsoy, N.A., … Kilic, E., Sahin, K.
    Year: 2024
    Citation: Chemical Biology and Drug Design, 103(1), e14439
  • Title: The effect of oral administration of undenatured type II collagen on monosodium iodoacetate-induced osteoarthritis in young and old rats
    Authors: Sahin, E., Orhan, C., Erten, F., … Durkee, S., Sahin, K.
    Year: 2023
    Citation: Scientific Reports, 13(1), 6499

Abdolghaffar Ownagh | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Prof Dr. Abdolghaffar Ownagh | Immunology and Microbiology | Best Researcher Award

Professor in microbiology Department at Urmia University, Iran

Prof. Dr. Abdolghaffar Ownagh is a distinguished academic and researcher in the field of veterinary microbiology, currently serving as a Professor in the Department of Microbiology at Urmia University, Iran. He holds a DVM and a DVSc in Microbiology, with extensive teaching experience spanning over three decades, covering courses in veterinary and medical mycology, bacteriology, and general microbiology. Dr. Ownagh has made significant contributions to the field, authoring numerous publications focused on microbial pathogenesis and the use of natural products in veterinary medicine. His research includes molecular detection of pathogens and antifungal treatments, showcasing a commitment to advancing veterinary science. Additionally, he has supervised the theses of multiple PhD and MSc students, fostering the development of future researchers. Dr. Ownagh’s expertise and dedication to teaching and research position him as a leading figure in veterinary microbiology, making substantial contributions to both academia and the scientific community.

Professional Profile

Education

Prof. Dr. Abdolghaffar Ownagh has a robust educational background in veterinary medicine and microbiology. He obtained his Doctor of Veterinary Medicine (DVM) degree from Urmia University, Iran, from 1987 to 1992, where he conducted his thesis on colibacillar diarrhea in calves. He furthered his studies by earning a Doctorate of Veterinary Science (DVSc) in Microbiology from the same institution between 2001 and 2007, focusing on the effects of various essential oils on fungi associated with Artemia urmiana. This comprehensive education has provided Dr. Ownagh with a solid foundation in veterinary science and microbiological research. His academic journey reflects a deep commitment to the field, equipping him with the necessary expertise to excel in teaching and research. Dr. Ownagh’s educational credentials have significantly contributed to his role as a leading figure in veterinary microbiology at Urmia University, where he continues to inspire and mentor future professionals in the field.

Professional Experience

Prof. Dr. Abdolghaffar Ownagh has amassed extensive professional experience in academia and research over his three-decade career. He is currently a Professor in the Department of Microbiology at Urmia University, Iran, where he has been instrumental in teaching a wide range of subjects, including veterinary and medical mycology, bacteriology, and general microbiology for DVM, MSc, and PhD students since 1993. In addition to his teaching responsibilities, Dr. Ownagh has supervised over 50 graduate and postgraduate theses, demonstrating his commitment to nurturing the next generation of researchers in veterinary sciences. His research efforts focus on microbial pathogenesis, antifungal treatments, and the application of natural products in veterinary medicine. Dr. Ownagh’s leadership in academia and his dedication to advancing knowledge in veterinary microbiology have established him as a prominent figure in his field, contributing significantly to both education and research initiatives at Urmia University.

Research Interest

Prof. Dr. Abdolghaffar Ownagh’s research interests encompass a broad spectrum within veterinary microbiology, with a strong emphasis on microbial pathogenesis and the exploration of natural products for therapeutic applications. His work primarily investigates the molecular detection and phylogenetic analysis of various pathogens affecting livestock, particularly focusing on zoonotic diseases and their impact on animal and human health. Dr. Ownagh has conducted significant research on the antifungal properties of essential oils and natural extracts, such as propolis, evaluating their effectiveness against fungal infections in veterinary settings. His studies also include the characterization of antibiotic resistance in bacterial pathogens and the development of innovative treatments for infections in animals. By integrating microbiological research with practical veterinary applications, Dr. Ownagh aims to enhance disease management strategies in livestock and contribute to the overall improvement of animal health and welfare. His commitment to advancing knowledge in this field positions him as a key contributor to veterinary science.

Award and honor

Prof. Dr. Abdolghaffar Ownagh has received several awards and honors throughout his distinguished academic and research career, recognizing his contributions to veterinary microbiology and education. His commitment to excellence in teaching has been acknowledged by the faculty at Urmia University, where he has played a pivotal role in shaping the curriculum and mentoring students at various academic levels. Dr. Ownagh’s research contributions have also garnered recognition within the scientific community, particularly for his innovative studies on microbial pathogenesis and the application of natural products in veterinary medicine. He has published extensively in reputable journals, earning accolades for his significant findings in the field. Additionally, Dr. Ownagh’s efforts to supervise and guide numerous graduate students have contributed to the development of future researchers, further solidifying his reputation as a dedicated educator and leader. These awards and honors reflect his unwavering dedication to advancing knowledge and improving practices within veterinary sciences.

Conclusion

Abdolghaffar Ownagh demonstrates strong qualifications for the Best Researcher Award, reflecting his extensive academic and research background, a significant body of work in microbiology, and a commitment to teaching and mentoring. By focusing on interdisciplinary collaborations, increasing his publication footprint, and pursuing more funding opportunities, he can further elevate his impact in the field of veterinary microbiology. His contributions are invaluable, making him a strong candidate for recognition in this prestigious award.

Publications top noted

  1. 🦠 Molecular survey and phylogenetic analysis of Bartonella henselae and Bartonella clarridgeiae in dogs from northwest Iran
    Rajabi, S.A., Ownagh, A., Hadian, M.
    Journal of Zoonotic Diseases, 2024, 8(4), pp. 610–620
  2. 🔬 Molecular and genotyping techniques in diagnosis of Coxiella burnetii: An overview
    Khademi, P., Tukmechi, A., Sgroi, G., Khalili, M., Mardani, K.
    Infection, Genetics and Evolution, 2024, 123, 105655
  3. 🐾 Molecular detection and phylogenetic analysis of Borrelia spp. in blood samples of cats and dogs by the nested-PCR method in West Azerbaijan Province, Iran
    Ownagh, A., Rajabi, S.A., Enferadi, A., Hadian, M.
    Brazilian Journal of Microbiology, 2024, 55(3), pp. 2915–2922
  4. 💧 Identification of a lytic bacteriophage against clinical isolates of Salmonella typhimurium in turkey poults
    Amini, M., Ownagh, A., Tukmechi, A., Allymehr, M.
    Veterinary Research Forum, 2024, 15(6), pp. 309–316
  5. 🐦 Molecular and histopathological survey of Francisella spp., Borrelia spp. and Leptospira spp. in ornamental birds of four provinces of Iran
    Enferadi, A., Ownagh, A., Nofouzi, K., Khordadmehr, M.
    Gene Reports, 2024, 35, 101921
  6. 🌱 Application of Propolis Ethanol Extract and Propolis Nanoemulsion in Treatment of Cutaneous Infection in Rabbit
    Archin, T., Ownagh, A., Tehrani, A.A., Keshipour, S.
    Iranian Journal of Veterinary Surgery, 2024, 19(1), pp. 8–18
  7. 🐄 Therapeutic effects of propolis ethanolic extract on infectious bovine keratoconjunctivitis in cows
    Bahmani, T., Najarnezhad, V., Ownagh, A.
    Journal of Advanced Veterinary Research, 2024, 14(4), pp. 586–590
  8. 🦎 First molecular detection of Francisella tularensis in turtle (Testudo graeca) and ticks (Hyalomma aegyptium) in Northwest of Iran
    Tukmechi, A., Ownagh, A., Enferadi, A., Khademi, P.
    International Journal for Parasitology: Parasites and Wildlife, 2024, 23, 100892
  9. 🐑 Molecular detection and phylogenetic analysis of Borrelia spp. from sheep and goats blood samples in West Azerbaijan province, Iran
    Enferadi, A., Ownagh, A., Tavassoli, M.
    Veterinary Research Forum, 2024, 15(2), pp. 89–95
  10. 🐱 Genomic detection and phylogenetic analysis of Bartonella quintana in pet cats from Urmia City, Northwest Iran
    Rajabi, S.A., Ownagh, A., Hadian, M.
    Comparative Immunology, Microbiology and Infectious Diseases, 2024, 105, 102125

Azizul Haque | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Assoc Prof Dr. Azizul Haque | Immunology and Microbiology | Best Researcher Award

Associate Professor at Medical University of South Carolina, United States

Dr. Azizul Haque, Ph.D., is an Associate Professor and Health Research Scientist with an extensive background in microbiology, immunology, and cancer research. With over two decades of experience in academic, research, and mentorship roles, he has contributed significantly to both scientific research and the development of future scholars. 🌍📚

Professional profile

Education📚

Dr. Haque holds a B.S. in Biology and an M.S. in Microbiology from Dhaka University, Bangladesh. He earned his Ph.D. in Microbiology and Immunology from Saga Medical School, Japan, followed by postdoctoral research at Indiana University School of Medicine in Immunology, Inflammation, and Cancer. 🎓🔬

Professional Experience🏛️

Dr. Haque has held various roles, including Associate Professor at the Medical University of South Carolina (MUSC) and Health Research Scientist at the Ralph Johnson VA Medical Center. He has also served in key research positions at institutions such as the Hollings Cancer Center and Indiana University. His expertise in cancer immunotherapy and neurodegenerative diseases highlights his interdisciplinary research approach. 🏫💡

Research Interest🌐

Dr. Haque’s research focuses on immunology, inflammation, and cancer. He is particularly interested in melanoma, prostate cancer, and neurodegenerative diseases like multiple sclerosis. His work integrates cancer biology and immunology, aiming to develop therapeutic strategies that enhance immune responses against tumors. 🔬🧠

Awards and Honors🏆

While specific awards and honors are not listed, Dr. Haque’s appointments and roles in prestigious institutions, such as MUSC and VA Medical Center, reflect his recognition in the field. His contributions to student mentorship and cancer research are likely to have earned him accolades throughout his career. 🏆👨‍🏫

Achievements 

  • Global Education: Completed a Ph.D. in Microbiology & Immunology in Japan, with postdoctoral research in the USA, reflecting a well-rounded international academic background.
  • Faculty Leadership: Associate Professor at the Medical University of South Carolina (MUSC) since 2010, playing a pivotal role in the Department of Microbiology and Immunology.
  • Interdisciplinary Research: Dual appointment in the Departments of Microbiology/Immunology and Neurosurgery, contributing to cancer immunotherapy and neurodegenerative disease research.
  • Health Research Scientist: Current Health Research Scientist at the Ralph Johnson VA Medical Center, focusing on immunological responses in cancer and inflammation.
  • Mentorship and Training: Served as an advisor and committee member for over 25 PhD and MS students, significantly contributing to graduate education.
  • Cancer Research Contributions: Made significant advances in the study of melanoma, prostate cancer, and multiple sclerosis, particularly in the area of immunological mechanisms.
  • Collaboration with Research Centers: Member of key research centers such as Hollings Cancer Center and Walther Oncology Center, contributing to cutting-edge cancer research.
  • International Teaching: Experience as a teaching assistant in Japan, as well as a long-standing mentor in graduate education programs at MUSC.
Publications top noted📜
  • “New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and neuroprotection”
    A. Haque, R. Polcyn, D. Matzelle, N.L. Banik
    Brain Sciences, 2018 | Cited by: 231 🧠🔬
  • “Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection”
    M.A. Haque, T. Mizobuchi, K. Yasufuku, T. Fujisawa, R.R. Brutkiewicz
    The Journal of Immunology, 2002 | Cited by: 214 🫁🦠
  • “Absence of γ-Interferon–inducible Lysosomal Thiol Reductase in Melanomas Disrupts T Cell Recognition of Select Immunodominant Epitopes”
    M.A. Haque, P. Li, S.K. Jackson, H.M. Zarour
    The Journal of Experimental Medicine, 2002 | Cited by: 177 🎯🦠
  • “Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration”
    M. Chakrabarti, A. Haque, N.L. Banik, P. Nagarkatti
    Brain Research Bulletin, 2014 | Cited by: 137 💊🧠
  • “Neuron specific enolase: a promising therapeutic target in acute spinal cord injury”
    A. Haque, S.K. Ray, A. Cox, N.L. Banik
    Metabolic Brain Disease, 2016 | Cited by: 128 🚑🧬
  • “Role of disulfide bonds in regulating antigen processing and epitope selection”
    P. Li, M.A. Haque, J.S. Blum
    The Journal of Immunology, 2002 | Cited by: 105 🧫⚙️
  • “Microgravity control of autophagy modulates osteoclastogenesis”
    Y. Sambandam, M.T. Townsend, J.J. Pierce, C.M. Lipman, A. Haque
    Bone, 2014 | Cited by: 100 🦴🔬
  • “Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65‐kDa heat shock protein”
    M.A. Haque, S. Yoshino, S. Inada
    European Journal of Immunology, 1996 | Cited by: 91 🐀🌡️
  • “Differential expression of Smad7 transcripts identifies the CD4+ CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts”
    T. Mizobuchi, K. Yasufuku, Y. Zheng, M.A. Haque
    The Journal of Immunology, 2003 | Cited by: 90 🧬🫁
  • “Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients”
    S.A. Imam, M.K. Guyton, A. Haque
    Journal of Neuroimmunology, 2007 | Cited by: 81 🧠🩺
  • “Cutting edge: induction of the antigen-processing enzyme IFN-γ-inducible lysosomal thiol reductase in melanoma cells is STAT1-dependent but CIITA-independent”
    P.W. O’Donnell, A. Haque
    The Journal of Immunology, 2004 | Cited by: 76 🔬⚙️
  • “Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition”
    M.A. Haque, J.W. Hawes, J.S. Blum
    The Journal of Immunology, 2001 | Cited by: 74 🧪👁️

Elimina Abiayi | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Dr. Elimina Abiayi | Immunology and Microbiology | Best Researcher Award

Director at National veterinary research institute vom, Nigeria

Elmina Abiba Abiayi is a distinguished researcher and leader in the field of microbiology and biotechnology. With extensive experience at the National Veterinary Research Institute (NVRI) in Nigeria, she has held various key positions, including Director of Special Services and Officer in Charge of Leptospira Research and Diagnosis. Her professional journey includes international exposure as a visiting scientist at the University of Florida, which has broadened her research perspective. Abiayi’s dedication to advancing diagnostic and research methodologies is evident in her leadership roles and contributions to veterinary science.

Professional profile

Education📚

Elmina Abiba Abiayi holds multiple advanced degrees including a PhD in Applied Microbiology and Biotechnology from the University of Jos, Nigeria. Her educational journey spans from a B.Sc. in Microbiology to a Fellowship in Medical Laboratory Technology, reflecting a deep commitment to her field and a solid foundation in microbiology and biotechnology.

Professional Experience🏛️

Abiayi’s professional experience is extensive and varied. She has held leadership positions at the National Veterinary Research Institute (NVRI), including Director of Special Services and Officer in Charge of Leptospira Research and Diagnosis. Her role involved significant responsibilities in diagnostic services, research, and laboratory management. Her experience includes international exposure as a visiting scientist at the University of Florida, which adds a global perspective to her expertise.

Research Interest🌐

Elmina Abiba Abiayi’s research interests are primarily focused on applied microbiology, particularly in the areas of animal disease diagnostics and vaccine development. Her work includes significant contributions to the control and prevention of zoonotic diseases, as well as advancements in laboratory techniques for better disease management. Her research also encompasses the development and improvement of vaccines for veterinary use, reflecting her commitment to enhancing public and animal health through scientific innovation.

Awards and Honors🏆

Abiayi’s accomplishments are underscored by several prestigious awards and fellowships. These include the IAEA Fellowship for Animal Diseases, the Norman E. Borlaug International Agricultural Science and Technology Fellowship, and participation in advanced training programs such as the AWARD Women’s Leadership and Management Course. These accolades highlight her leadership, research capability, and dedication to advancing science.

Publication📜
  • Effect of single and combination therapy on methanol extracts of Khaya senegalensis stem bark, Vernonia amygdalina leaves and Garcinia kola seed in Leptospira interrogans-infected mice
    • Authors: Abiayi, E.A., Itelima, J.U., Onwuliri, F.C., Agida, G., Forcados, G.
    • Journal: Journal of Ethnopharmacology
    • Year: 2024
    • Volume: 335
    • Article Number: 118601
    • Citations: 0 🌟
  • Pathogenic Leptospira interrogans in Jos North Abattoir, Nigeria: Occurrence, serology, and molecular characterization
    • Authors: Abiayi, E.A., Itelima, J.U., Onwuliri, F.C., ThankGod, D.G., Meseko, C.
    • Journal: Comparative Immunology, Microbiology and Infectious Diseases
    • Year: 2024
    • Volume: 112
    • Article Number: 102223
    • Citations: 0 🌟
  • Analysis of Retrospective Laboratory Data on the Burden of Bacterial Pathogens Isolated at the National Veterinary Research Institute Nigeria, 2018–2021
    • Authors: Kabantiyok, D., Gyang, M.D., Agada, G.O., Adegboye, O.A., Emeto, T.I.
    • Journal: Veterinary Sciences
    • Year: 2023
    • Volume: 10(8)
    • Article Number: 505
    • Citations: 1 🌟
  • Isolation and molecular characterization of pathogenic Leptospira species from cattle in Zaria and its environs, Kaduna State, Nigeria
    • Authors: Udechukwu, C.C., Kudi, C.A., Abdu, P.A., Okoronkwo, M.O., Adekola, A.A.
    • Journal: Comparative Immunology, Microbiology and Infectious Diseases
    • Year: 2023
    • Volume: 99
    • Article Number: 102003
    • Citations: 3 🌟
  • Serological and molecular epidemiology of leptospirosis and the role of dogs as sentinel for human infection in Nigeria
    • Authors: Pilau, N.N., Lubar, A.A., Daneji, A.I., Vinetz, J.M., Matthias, M.A.
    • Journal: Heliyon
    • Year: 2022
    • Volume: 8(5)
    • Article Number: e09484
    • Citations: 8 🌟
  • Haematology of captive wild African giant (Cricetomys gambianus) and brown (Rattus norvegicus) rats sero-positive for Leptospira spp. around Zaria
    • Authors: Udechukwu, C.C., Kudi, C.A., Abdu, P.A., Ogbuagu, N.E., Oyetunde, J.S.
    • Journal: Comparative Clinical Pathology
    • Year: 2021
    • Volume: 30(3)
    • Pages: 441–444
    • Citations: 0 🌟
  • Prevalence of Leptospira interrogans in wild rats (Rattus norvegicus and Cricetomys gambianus) in Zaria, Nigeria
    • Authors: Udechukwu, C.C., Kudi, C.A., Abdu, P.A., Abiayi, E.A., Orakpoghenor, O.
    • Journal: Heliyon
    • Year: 2021
    • Volume: 7(1)
    • Article Number: e05950
    • Citations: 6 🌟
  • Occurrence of leptospirae antibodies in abattoir workers in parts of north central Nigeria
    • Authors: Abiayi, E.A., Inabo, H.I., Jatau, E.D., Sar, T.T., Dangeri, M.A.
    • Journal: Research Journal of Immunology
    • Year: 2015
    • Volume: 8(1)
    • Pages: 27–34
    • Citations: 4 🌟
  • Knowledge, attitudes, risk factors and practices (KARP) that favor leptospira infection among abattoir workers in North Central Nigeria
    • Authors: Abiayi, E.A., Inabo, H.I., Jatau, E.D., Kumbish, P.R., Okewole, P.A.
    • Journal: Asian Journal of Epidemiology
    • Year: 2015
    • Volume: 8(4)
    • Pages: 104–113
    • Citations: 12 🌟